Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing
F Morady,
E Shen,
A Schwartz,
D Hess,
A Bhandari,
RJ Sung,
and
MM Scheinman
Electrophysiologic testing was performed in 53 patients with recurrent syncope that remained unexplained despite a thorough neurologic and noninvasive cardiac evaluation. Fifteen patients had no structural heart disease, 9 had mitral valve prolapse and 29 had structural heart disease other than mitral valve prolapse. Nonsustained ventricular tachycardia was induced in 15 patients (28%), sustained ventricular tachycardia was induced in 9 (17%), ventricular fibrillation was induced in 4 (8%) and sinus node function was abnormal in 2 (4%). Female sex and lack of structural heart disease were independently associated with a negative electrophysiologic study (p less than 0.001). Patients with inducible ventricular tachycardia or ventricular fibrillation were treated with drugs selected on the basis of the results of electropharmacologic testing. The recurrence rate of syncope was 43% over a 31 +/- 10 month period (mean +/- standard deviation) of follow-up in patients with a negative electrophysiologic study, 40% over a 22 +/- 6 month period in patients with inducible nonsustained ventricular tachycardia, 0% over a 30 +/- 12 month period in patients with inducible sustained ventricular tachycardia and 25% over a 21 +/- 10 month period in patients with inducible ventricular fibrillation. In patients with recurrent unexplained syncope undergoing electrophysiologic testing, a potential cause of syncope is least likely to be found in women without structural heart disease. The results of programmed ventricular stimulation must be interpreted with regard to the method of induction of ventricular tachycardia and the type of ventricular tachycardia induced. The excellent response rate in patients with inducible sustained ventricular tachycardia whose therapy is guided by the results of electropharmacologic testing suggests that sustained ventricular tachycardia is a clinically significant response.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
B. Brembilla-Perrot, C. Suty-Selton, D. Beurrier, P. Houriez, M. Nippert, A. Terrier de la Chaise, P. Louis, O. Claudon, M. Andronache, A. Abdelaah, et al.
Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing
J. Am. Coll. Cardiol.,
August 4, 2004;
44(3):
594 - 601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Pezawas, G. Stix, J. Kastner, M. Wolzt, C. Mayer, D. Moertl, and H. Schmidinger
Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantablecardioverter defibrillator therapy
Europace,
January 1, 2003;
5(3):
305 - 312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Andrews, R. I. Fogel, G. Pelargonio, J. J. Evans, and E. N. Prystowsky
Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: A comparison with patients known to have sustained ventricular tachycardia
J. Am. Coll. Cardiol.,
December 1, 1999;
34(7):
2023 - 2030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R A Kenny and A D Krahn
Implantable loop recorder: evaluation of unexplained syncope
Heart,
April 1, 1999;
81(4):
431 - 433.
[Full Text]
|
 |
|

|
 |

|
 |
 
A. D. Krahn, G. J. Klein, R. Yee, T. Takle-Newhouse, and C. Norris
Use of an Extended Monitoring Strategy in Patients With Problematic Syncope
Circulation,
January 26, 1999;
99(3):
406 - 410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Krahn, G. J. Klein, C. Norris, and R. Yee
The Etiology of Syncope in Patients With Negative Tilt Table<$DOWNLINK> and Electrophysiological Testing
Circulation,
October 1, 1995;
92(7):
1819 - 1824.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. J. Klein, B. J. Gersh, and R. Yee
Electrophysiological Testing : The Final Court of Appeal for Diagnosis of Syncope?
Circulation,
September 1, 1995;
92(5):
1332 - 1335.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. P. DiMarco and J. T. Philbrick
Use of Ambulatory Electrocardiographic (Holter) Monitoring
Ann Intern Med,
July 1, 1990;
113(1):
53 - 68.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Manolis, M. Linzer, D. Salem, and N. A. M. Estes III
Syncope: Current Diagnostic Evaluation and Management
Ann Intern Med,
June 1, 1990;
112(11):
850 - 863.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Denes, E. Uretz, M. D. Ezri, and J. Borbola
Clinical Predictors of Electrophysiologic Findings in Patients With Syncope of Unknown Origin
Arch Intern Med,
September 1, 1988;
148(9):
1922 - 1928.
[Abstract]
[PDF]
|
 |
|
|